FRNM Latest Press Releases

-- October 20, 2026 --

Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen Lung Test With FDA-Approved SimpleScreen CRC Option Globe Newswire 8:30 AM

-- October 15, 2026 --

Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026 Globe Newswire 4:29 PM

-- October 11, 2026 --

Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026 Globe Newswire 1:00 PM

-- August 12, 2026 --

FDA Grants Breakthrough Device Designation to Freenome's Blood-Based SimpleScreen Lung Cancer Screening Test Globe Newswire 9:00 AM

-- July 27, 2026 --

FDA Approves Freenome's SimpleScreen CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes